JP2002528123A5 - - Google Patents

Download PDF

Info

Publication number
JP2002528123A5
JP2002528123A5 JP2000579757A JP2000579757A JP2002528123A5 JP 2002528123 A5 JP2002528123 A5 JP 2002528123A5 JP 2000579757 A JP2000579757 A JP 2000579757A JP 2000579757 A JP2000579757 A JP 2000579757A JP 2002528123 A5 JP2002528123 A5 JP 2002528123A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
antigen
sequence
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000579757A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002528123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/026291 external-priority patent/WO2000026385A1/en
Publication of JP2002528123A publication Critical patent/JP2002528123A/ja
Publication of JP2002528123A5 publication Critical patent/JP2002528123A5/ja
Pending legal-status Critical Current

Links

JP2000579757A 1998-11-05 1999-11-05 遺伝子免疫のための核酸構築物 Pending JP2002528123A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10716998P 1998-11-05 1998-11-05
US60/107,169 1998-11-05
PCT/US1999/026291 WO2000026385A1 (en) 1998-11-05 1999-11-05 Nucleic acid constructs for genetic immunization

Publications (2)

Publication Number Publication Date
JP2002528123A JP2002528123A (ja) 2002-09-03
JP2002528123A5 true JP2002528123A5 (cg-RX-API-DMAC7.html) 2006-12-21

Family

ID=22315199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000579757A Pending JP2002528123A (ja) 1998-11-05 1999-11-05 遺伝子免疫のための核酸構築物

Country Status (13)

Country Link
EP (1) EP1119630B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002528123A (cg-RX-API-DMAC7.html)
AT (1) ATE315658T1 (cg-RX-API-DMAC7.html)
AU (1) AU775939B2 (cg-RX-API-DMAC7.html)
CA (1) CA2349505A1 (cg-RX-API-DMAC7.html)
CY (1) CY1105600T1 (cg-RX-API-DMAC7.html)
DE (1) DE69929470T2 (cg-RX-API-DMAC7.html)
DK (1) DK1119630T3 (cg-RX-API-DMAC7.html)
ES (1) ES2257879T3 (cg-RX-API-DMAC7.html)
IL (1) IL142980A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ512078A (cg-RX-API-DMAC7.html)
PT (1) PT1119630E (cg-RX-API-DMAC7.html)
WO (1) WO2000026385A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024887A2 (en) * 2000-09-19 2002-03-28 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
EP1220697B1 (en) 1999-10-11 2004-12-29 Felton International, Inc. Universal anti-infectious protector for needleless injectors
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
ATE320493T1 (de) * 2000-06-22 2006-04-15 Ucb Pharma Ltd Modifizierung des hepatitis b kernantigens
BR0209854A (pt) * 2001-05-18 2004-06-08 Powderject Vaccines Inc Molécula de ácido nucléico recombinante, cassete de expressão, vetor, polipeptìdeo, composição de vacina, dispositivo de aceleração de partìcula, e, método para gerar uma resposta imune celular em um indivìduo
DE10143490C2 (de) * 2001-09-05 2003-12-11 Gsf Forschungszentrum Umwelt Rekombinantes MVA mit der Fähigkeit zur Expression von HCV Struktur-Antigenen
NZ539107A (en) 2002-09-27 2008-11-28 Powderject Res Ltd Nucleic acid coated particles
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
CN1747970A (zh) 2003-02-06 2006-03-15 三肽公司 抗原/抗体或配体/受体糖基化的特异性交换剂
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
BRPI0922561A2 (pt) 2008-12-09 2020-08-11 Pfizer Vaccines Llc vacina de peptídeo de ch3 da ige.
CN102596236B (zh) 2009-07-30 2015-06-24 辉瑞疫苗有限责任公司 抗原性Tau肽及其用途
KR101660578B1 (ko) 2009-09-03 2016-09-27 화이자 백신스 엘엘씨 Pcsk9 백신
EP2575868A1 (en) 2010-06-07 2013-04-10 Pfizer Vaccines LLC Ige ch3 peptide vaccine
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
US9403879B2 (en) * 2011-02-11 2016-08-02 The Trustees Of The University Of Pennsylvania Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine

Similar Documents

Publication Publication Date Title
Ulrich et al. Core particles of hepatitis B virus as carrier for foreign epitopes
Celis et al. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen
EP1685251B1 (en) Nucleic acid constructs
JP2004527213A5 (cg-RX-API-DMAC7.html)
JP2002512026A5 (cg-RX-API-DMAC7.html)
JP2002528060A5 (cg-RX-API-DMAC7.html)
CA2325566A1 (en) Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
CA2413546A1 (en) Modification of hepatitis b core antigen
JP2001512748A5 (cg-RX-API-DMAC7.html)
CA2305683A1 (en) Immunogenic peptides from the hpv e7 protein
US6492145B1 (en) Vaccine against mycobacterial infections
JP2002517249A5 (cg-RX-API-DMAC7.html)
EP1075520A1 (en) Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate
Morgan et al. Comparative immunogenicity studies on Epstein‐Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton‐top tamarins
US6221664B1 (en) Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method
JP2010538629A (ja) 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用
JP2004536107A5 (cg-RX-API-DMAC7.html)
Chengalvala et al. Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid
JP2002516662A5 (cg-RX-API-DMAC7.html)
CN118286410B (zh) 一种偶联CD8抗体的肿瘤mRNA疫苗的制备方法
Sjolander et al. Bacterial Expression Systems Based on a Protein A and Protein G Designed for the Production of Immunogens: Applications to Plasmodium falciparum Malaria Antigens
AU700104B2 (en) Prolactin as a vaccine adjuvant
JP2003286189A (ja) 中空ナノ粒子を形成するタンパク質に疾患治療用の細胞導入物質を融合させた薬剤
KR100905249B1 (ko) Dna와 항원의 조합에 의해 효능이 증강된 백신포뮬레이션
Sanchez et al. Evidence for the presence of repeating antigenic determinants in the major and minor polypeptides derived from hepatitis B surface antigen